With its growing healthcare infrastructure, the United Kingdom is expected to lead Europe's INR test meter market. The Hospital segment is expected to register a CAGR of 7.8% during the forecast period 2022-2032, indicating that there will be positive growth in this industry over time frame as well!
NEWARK, Del., July 5, 2022 /PRNewswire/ -- As per Future Market Insights, the global INR test meter market was around US$ 1.2 Bn in 2021, and is projected to exhibit a CAGR growth of close to 6.3% over the forecast period, exceeding valuation of US$ 2.4 Bn in 2032.
Patients with coagulopathic aberrations related to pathological conditions have a strong reliance on PT diagnostic platforms. Patients who take warfarin frequently have medical conditions that put them at high risk for severe illness, including hospitalization, intensive care admissions, and death, as per the Centers for Disease Control and Prevention.
With the emerging importance of utilizing point-of-care tests, the market for INT test meters is set to witness high demand during the forecast period (2022-2032). One of the primary factors driving the growth of the INR test mater market is rising prevalence of cardiovascular diseases and blood disorders across the globe.
Get Sample PDF Brochure: https://www.futuremarketinsights.com/reports/sample/rep-gb-15124
Demand for INR test meters is expected to grow due to increased awareness of these disorders, which will improve diagnostic rates and preventive care management. Further, with favorable government funds and investments for acquiring and installing such medical devices in public healthcare facilities, the demand in the market is projected to surge through 2022 & beyond.
Key Takeaways from Market Study
- In terms of product, devices held approximately 79.7% of market value share in 2021, owing to their efficacy in delivering positive therapeutic outcomes.
- Based on end users, hospitals segment is expected to register a CAGR of 7.8% during the forecast period.
- North America is considered as the leading region with a value share of 35.6% in 2021, owing to high lifestyle associated disease cases, and rapid device approvals.
- The U.K. is expected to lead the growth in Europe INR test meter market backed by its development in healthcare infrastructure.
"Growing advancements of digital solutions for medical use is set to propel the sales of the INR test meter market across the globe," says an analyst of Future Market Insights.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15124
Market Competition
Key manufacturers in the INR test meter market are adopting strategic approaches such as mergers and research activities for revenue growth and product portfolio expansion. Producers are also engaged in several patent expiry mitigation approaches to further provide upgraded product lines, thus establishing a strong geographical outlook.
- In November 2021, CoaguSense Inc. incorporated a novel "Prothrombin Time Home Testing System" connected with MedM remote care platform.
- In May 2021, Biosynex acquired Avalun to become a European leader in rapid diagnostic testing.
Key Companies Profiled
- F. Hoffmann-La Roche Ltd
- Lepu Medical Technology(Beijing)Co., Ltd.
- ACON Laboratories, Inc.
- CoaguSense Inc.
- Abbott
- Eurolyser Diagnostica GmbH
- Horiba ABX SAS
- Avalun SAS
Key Market Segments Covered in INR Test Meter Industry Research
By Product:
- Device
- Lancet
- Test Strips
By End User:
- Hospitals
- Speciality Clinics
- Ambulatory Surgical Centers
- Home care settings
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15124
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the INR test meter market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.
The research study is based on the product – (device, lancet, and test strips), by end user (hospitals, speciality clinics, ambulatory surgical centres, and home care settings), across seven key regions of the world.
About Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Key Promotional Strategies, By Key Manufacturers
4.2. Regulatory Scenario
4.3. Reimbursement Scenario
4.4. Porter's Analysis
4.5. PESTLE Analysis
5. COVID-19 Crisis Analysis
5.1.1. Current COVID-19 Statistics and Probable Future Impact
5.1.2. COVID-19 and Impact Analysis
5.1.2.1. Revenue by Product
5.1.2.2. Revenue by End User
5.1.2.3. Revenue by Region
Have a Look at Related Research Reports:
PD-L1 Biomarker Testing Market Growth is projected to reach a valuation of US$ 597.9 Mn in 2022, with demand increasing at a robust 9.4% CAGR over the forecast period 2022-2032 - Comprehensive Research Report by FMI
Americas COVID-19 Testing Market Analysis size in the Americas is expected to surpass US$ 7,264.4 Mn by 2031 - Comprehensive Research Report by FMI
Formulation Development Outsourcing Market Growth is expected to grow from US$ 31 billion in 2021 to US$ 66.6 billion by 2032 - Comprehensive Research Report by FMI
Lab Screening Test Kit Market Trends Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030 | Comprehensive Research Report by FMI
Ovulation Test Kit Market Share is likely to expand to US$ 450 Million by 2032 - Comprehensive Research Report by FMI
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/inr-test-meter-market
LinkedIn| Twitter| Blogs
Share this article